In a separate experimental study, HCT116 colon cancer cells underwent combined treatment involving CFI and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL). This evidence concerns the gene TNFSF10 and malignant colon neoplasm.